Story perspectives
FDA Grants Breakthrough Status to Aidoc's AI Imaging Device
10/1/2025
50 11
1 of 1
Story summary
- Aidoc receives Breakthrough Device Designation from the Food and Drug Administration (FDA) for multi-triage CT.
- The CARE model enables simultaneous coverage of pathologies.
- Designation allows parallel FDA review of indications under one submission.
- AI adoption in imaging rises due to staffing shortages and 160-minute waits.
- Walach says the designation validates potential to improve quality care; Braginsky stresses integration.
